Evidence of the cross-cultural stability of the factor structure of the SKT short test for assessing deficits of memory and attention

International Psychogeriatrics

Volumn 9, Issue 2, 1997, Pages 139-153

  Lehfeld, Hartmut ^a   Rudinger, Georg ^b   Rietz, Christian ^b   Heinrich, Claus ^a   Wied, Viktor ^c   Fornazzari, Luis ^d   Pittas, Johannes ^e   Hindmarch, Ian ^f   Erzigkeit, Hellmut ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c Bektherev Institut   (Russian Federation)

^d UNIVERSITY OF CHILE   (Chile)

^e Psychiatric Hospital   (Greece)

^f UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMNESIA; ARTICLE; ATTENTION DEFICIT DISORDER; CHILE; COGNITION; CULTURAL FACTOR; DEMENTIA; FACTORIAL ANALYSIS; FEMALE; GERMANY; GREECE; HEALTH SERVICES RESEARCH; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGIC TEST; PSYCHOMETRY; RUSSIAN FEDERATION; SAMPLE; STATISTICAL ANALYSIS; TASK PERFORMANCE; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATTENTION; CROSS-CULTURAL COMPARISON; DEMENTIA; FEMALE; HUMANS; MALE; MENTAL RECALL; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OBSERVER VARIATION; PSYCHOMETRICS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS;

EID: 0030690357     PISSN: 10416102     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1041610297004304     Document Type: Article

References (43)

1. Amaducci, L., Angst, J., Bech, P., Benkert, O., Bruinvels, J., et al. (1990). Consensus conference on the methodology of clinical trials of "nootropics," Munich, June 1989. Pharmacopsychiatry, 23, 171-175.
2. American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., rev.). Washington, DC: Author.
3. American Psychological Association. (1985). Standards for educational and psychological testing. Washington, DC: Author.
4. Angst, J., Bech, B., Bruinvels, J., Engel, R. R., Ferner, U., et al. (1994). Report on the fifth consensus conference: Methodology of long-term clinical trials in psychiatry. Pharmacopsychiatry, 27, 101-107.
5. Bernhardt, T., Kübler, J., & Erzigkeit, H. (1994). Hirnleistungsstörungen im Alter. Nimodipin in der niedergelassenen Praxis [Cerebral performance deficits in the elderly. General practitioners' experiences with nimodipine]. Kassenarzt, 31/32, 35-39.
6. Blaha, L., Erzigkeit, H., Adamczyk, A., Freytag, S., & Schaltenbrand, R. (1989). Clinical evidence of the effectiveness of vinpocetine in the treatment of organic psychosyndrome. Human Psychopharmacology, 4, 103-111.
7. Clinical Research Working Group from the Pharmaceutical Industry on Dementia. (1990). Recommendations for clinical drug trials in dementia. Dementia, 1, 292-295.
8. CPMP Working Party on Efficacy of Medicinal Products. (1992, November). Antidementia medicinal products. Note for guidance (Draft 5). Commission of the European Communities, III/3705-91-EN.
9. Ditzler, K. (1991). Efficacy and tolerability of Memantine in patients with dementia syndrome. A double-blind, placebo controlled trial. Arzneimittelforschung/Drug Research, 41, 773-780.
10. Efron, B. (1979). Bootstrap methods: Another look at the jackknife. Annals of Statistics, 7, 1-26.
11. Efron, B., & Tibshirani, R. (1993). An introduction to bootstrap. New York: Chapman & Hall.
12. Erzigkeit, H. (1989a). SKT - Ein Kurztest zur Erfassung von Gedächtnis- und Aufmerksamkeitsstörungen [SKT - A short cognitive performance test for assessing deficits of memory and attention]. Weinheim, Germany: Beltz.
13. Erzigkeit, H. (1989b). The SKT - A short cognitive performance test as an instrument for the assessment of clinical efficacy of cognition enhancers. In M. Bergener & B. Reisberg (Eds.), Diagnosis and treatment of senile dementia (pp. 164-174). Berlin: Springer-Verlag.
14. Erzigkeit, H. (1991). The development of the SKT project. In I. Hindmarch, H. Hippius, & G. K. Wilcock (Eds.), Dementia: Molecules, methods and measures, (pp. 101-108). Chichester, England: Wiley.
15. Erzigkeit, H. (1992). SKT: A short cognitive performance test for assessing memory and attention. Manual, Concise version. Witten, Germany: Geromed.
16. Fenzl, E., Apecechea, M., Schaltenbrand, R., & Friedel, R. (1986). Long term study concerning tolerance and efficacy of Vinpocetine in elderly patients suffering from a mild to moderate organic psychosyndrome due to cerebral metabolic disturbances. In J. Krieglstein (Ed.), Pharmacology of cerebral ischemia (pp. 435-439). New York: Elsevier.
17. Fischhof, P. K., Saletu, B., Rüther, E., Litschauer, G., Möslinger-Gehmayr, R., et al. (1992). Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID). Neuropsychobiology, 26, 65-70.
18. Fischhof, P. K., Wagner, G., Littschauer, L., Rüther, E., Apecechea, M., et al. (1989). Therapeutic results with Nimodipine in primary degenerative dementia and multi-infarct dementia. In M. Bergener & B. Reisberg (Eds.), Diagnosis and treatment of senile dementia (pp. 350-359). Berlin: Springer-Verlag.
19. Grossmann, W. M., Standl, A., May, U., van Laak, H.-H., & Hirche, H. (1990). Naftidrofuryl in the treatment of mild dementia. A double-blind study. Pharmacopsychiatry, 23, 265-273.
20. Hambleton, R. K. (1994). Guidelines for adapting educational and psychological tests: A progress report. In van der Vijver (Ed.), Bulletin of the International Test Commission Manual (pp. 229-244). Bern, Switzerland: Hogrefe u. Huber.
21. Herrmann, W., & Stephan, K. (1992). Moving from the question of efficacy to the question of therapeutic relevance: An exploratory reanalysis of a controlled clinical study of 130 inpatients with dementia syndrome taking piracetam. International Psychogeriatrics, 4, 25-44.
22. Hindmarch, I., Fuchs, H. H., & Erzigkeit, H. (1991). Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes. International Clinical Psychopharmacology, 6, 31-43.
23. Kanowski, S., Fischhof, P., Hiersemenzel, R., Röhmel, J., & Kern, U. (1989). Therapeutic efficacy of nootropic drugs - A discussion of clinical phase III studies with nimodipine as a model. In M. Bergener & B. Reisberg (Eds.), Diagnosis and treatment of senile dementia (pp. 339-349). Berlin: Springer-Verlag.
24. Kanowski, S., Herrmann, W. M., Stephan, K., Wierich, W., & Hörr, R. (1996). Proof of efficacy of the Gingko biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry, 29, 47-56.
25. Kaszniak, A. W., Poon, L. W., & Riege, W. (1991). Assessing memory deficits: An information processing approach. In L. W. Poon (Ed.), Handbook for clinical memory assessment of older adults (pp. 168-188). Washington, DC: American Psychological Association.
26. Kausler, D. H. (1991). Experimental psychology, cognition, and human aging (2nd ed.). New York: Springer-Verlag.
27. Kim, Y. S., Nibbelink, D. W., & Overall, J. E. (1993). Factor structure and scoring of the SKT test battery. Journal of Clinical Psychology, 49, 61-71.
28. Lauter, H. (1980). Demenzen. In U. H. Peters (Ed.), Die Psychologie des 20. Jahrhunderts [Dementing disorders] (pp. 637-663). Zürich, Switzerland: Band X. Kindler.
29. Lonner, W. F. (1990). An overview of cross-cultural testing and assessment. In R. W. Brislin (Ed.), Applied cross-cultural psychology (pp. 56-76). Newbury Park, CA: Sage.
30. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., et al. (1984). Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939-944.
31. Overall, J. E., & Schaltenbrand, R. (1992). The SKT neuropsychological test battery. Journal of Geriatric Psychiatry and Neurology, 5, 220-227.
32. Poortinga, Y. H. (1989). Equivalence of cross-cultural data: An overview of basic issues. International Journal of Psychology, 24, 737-756.
33. Poortinga, Y. H., & van der Flier, H. (1988). The meaning of item bias in ability tests. In S. H. Irvine & J. W. Berry (Eds.), Human abilities in cultural context (pp. 166-183). Cambridge: Cambridge University Press.
34. Poortinga, Y. H., & Malpass, R. S. (1986). Making inferences from cross-cultural data. In W. J. Lonner & J. W. Berry (Eds.), Field methods in cross-cultural research (pp. 17-46). Beverly Hills, CA: Sage.
35. Rietz, C. (1997). Faktorielle Invarianz [On factorial invariance]. Bonn, Germany: PACE.
36. Sartorius, N., & Kuyken, W. (1994). Translation of health status instruments. In J. Orley & W. Kuyken (Eds.), Quality of life assessment in health care settings (pp. 3-18). Berlin: Springer-Verlag.
37. Schmidt-Gollas, N., & Erzigkeit, H. (1993). Ways of constructing a therapy sensitive scale for the assessment of ADL aspects of cognitively impaired elderly patients. In M. Bergener, R. H. Belmaker, & M. S. Tropper (Eds.), Psychopharmacotherapy for the elderly. Research and clinical implications (pp. 119-131). New York: Springer Publishing Co.
38. Sickmüller, B., & Throm, S. (1993). International Conference on Harmonisation (ICH). Sachstand. Pharmaceutical Industry, 55, 1-5.
39. Ten Berge, J. M. F. (1986a). Some relationships between descriptive comparisons of components from different studies. Multivariate Behavioral Research, 21, 29-40.
40. Ten Berge, J. M. F. (1986b). Rotation to perfect congruence and the cross-validation of component weights across populations. Multivariate Behavioral Research, 21, 41-64.
41. Watkins, D. (1989). The role of confirmatory factor analysis in cross-cultural research. International Journal of Psychology, 24, 685-701.
42. Weyer, G., Erzigkeit, H., Hadler, D., & Kubicki, S. (1996). Efficacy and safety of idebenone in the long-term treatment of Alzheimer's disease: A double-blind, placebo controlled multicentre study. Human Psychopharmacology, 11, 53-65.
43. World Health Organization. (1991). Evaluation of methods for the treatment of mental disorders. WHO Technical Report Series 812, Geneva, Switzerland.